mifepristone has been researched along with alprostadil in 102 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (11.76) | 18.7374 |
| 1990's | 54 (52.94) | 18.2507 |
| 2000's | 26 (25.49) | 29.6817 |
| 2010's | 9 (8.82) | 24.3611 |
| 2020's | 1 (0.98) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Aguillaume, CJ; Baulieu, EE; Chemama, L; Renault, M; Rezvani, Y; Silvestre, L; Ulmann, A | 1 |
| Baird, DT; Thong, KJ | 2 |
| Baird, DT; Dewar, MH; Thong, KJ | 1 |
| Henshaw, RC; Naji, SA; Russell, IT; Templeton, AA | 3 |
| Baird, DT; Norman, JE; Rodger, MW; Thong, KJ | 1 |
| Henshaw, RC; Murray, GI; Smith, AP; Smith, NC | 1 |
| Ferguson, J; Hill, NC; MacKenzie, IZ | 1 |
| Chard, T; Kitau, M; Olajide, F | 1 |
| Guillebaud, J; Heard, M | 1 |
| Henshaw, RC; Templeton, AA | 1 |
| Tang, GW | 1 |
| Aubeny, E; Baulieu, EE | 1 |
| Baulieu, EE; Dubois, C; Renault, M; Rezvani, Y; Silvestre, L; Ulmann, A | 1 |
| Baird, DT; Rodger, MW | 3 |
| Baird, DT; Logan, AF; Rodger, MW | 1 |
| Dubois, C; Ulmann, A | 1 |
| Bohn, H; Chapman, MG; Chard, T; Grudzinskas, JG; Holly, JM; Howell, RJ; Olajide, F; Wass, JA | 1 |
| Chard, T; Grudzinskas, G; Howell, RJ; Olajide, F; Teisner, B | 1 |
| Barnes, K; Brandon, DD; Brightwell, D; Chrousos, GP; Kawai, S; Knazek, RA; Laue, L; Loriaux, DL | 1 |
| Templeton, AA; Urquhart, DR | 1 |
| Aubeny, E; Baulieu, EE; Dubois, C; Elia, D; Jourdan, MC; Leton, M; Ulmann, A; Van den Bosch, MC | 1 |
| Baird, DT; Cameron, IT; Roberts, I; Rodger, M | 1 |
| Baird, DT; Cameron, IT | 1 |
| Baird, DT; Cameron, IT; Michie, AF | 1 |
| Baird, DT; Norman, JE; Thong, KJ | 1 |
| Sernia, C; Thomas, WG | 1 |
| Baird, DT; Lynch, P; Thong, KJ | 2 |
| Baird, DT; Sukcharoen, N; Thong, KJ | 1 |
| Norman, JE | 1 |
| Brennand, JE; Cabrol, D; Calder, AA; Carbonne, B; Maria, B | 1 |
| Ho, PC; Ma, HK; Tsang, SS | 1 |
| Henshaw, R; Naji, S; Russell, I; Templeton, A | 1 |
| Peplow, PV | 1 |
| Bygdeman, M; Gemzell-Danielsson, K; Gottlieb, C; Swahn, ML | 1 |
| Silvestre, L; Ulmann, A | 1 |
| Baird, DT | 2 |
| Bates, A; Evans, J; Pinto, A | 1 |
| Campbell, DM; Hinshaw, K; Knox, FM; Levy, DM; Sutherland, HW | 1 |
| Lau, OW; Tang, GW; Yip, P | 1 |
| el-Refaey, H; Hinshaw, K; Templeton, A | 1 |
| Olund, A; Somell, C | 1 |
| Chan, YF; Ho, PC; Ma, HK | 1 |
| Choolani, M; Prasad, RN; Ratnam, SS; Roy, A | 1 |
| Joly, P; Lauret, P; Lecorvaisier-Pieto, C; Noblet, C; Tanasescu, S; Thomine, E | 1 |
| Chan, YF; Ho, PC; Lau, W | 1 |
| Choolani, M; Prasad, RN | 1 |
| Henshaw, RC; Howie, FL; Naji, SA; Russell, IT; Templeton, AA | 1 |
| Aubeny, E | 1 |
| Davey, A; Sakiz, E; Sitruk-Ware, R | 1 |
| Grant, KE; MacKenzie, IZ; Mardon, HJ; McCracken, SA; Redman, CW | 1 |
| Larsen, JF; Lidegaard, O | 1 |
| Brooks, L; Grinsted, J; Grinsted, L; Jacobsen, JD; Nielsen, SP; Sandstrøm, O; Schantz, A | 1 |
| Bouchard, P; Christin-Maitre, S; Spitz, IM | 1 |
| Jørgensen, JJ; Olsen, CD; Wittendorff, HE | 1 |
| Bygdeman, M; Danielsson, KG; Marions, L | 1 |
| Gemzell-Danielsson, K; Ostlund, E | 1 |
| Colov, NS; Hansen, PS; Lindhardt, TB; Walker, LR | 1 |
| Baird, DT; Bartley, J; Everington, D; Tong, S | 1 |
| El-Refaey, H; Hoffman, L; le Roux, PA; Nooh, R; Pahal, GS; Rodeck, CH | 1 |
| Baird, DT; Tang, OS; Thong, KJ | 1 |
| Baird, DT; Bartley, J; Brown, A; Elton, R | 1 |
| Honkanen, H; von Hertzen, H | 1 |
| Bygdeman, M; Danielsson, KG | 1 |
| Baird, DT; Bartley, J | 1 |
| Piskorowskyj, N; Vyjayanthi, S | 1 |
| Blumenfeld, B; Shakhar, G | 1 |
| Nilas, L; Petersen, MB; Rørbye, C | 1 |
| Darney, PD; Meckstroth, KR | 1 |
| Nilas, L; Nørgaard, M; Rørbye, C; Vestermark, V | 1 |
| Tinelli, A; Tinelli, FG; Tinelli, R | 1 |
| Acharya, G; Bråthen, A; Haugen, M; Maltau, JM; Nilsen, I | 1 |
| Nothnagle, M; Taylor, JS | 1 |
| Nilas, L; Nørgaard, M; Rørbye, C | 2 |
| Baird, DT; Critchley, HO; Henderson, TA; Kelly, RW; Milne, SA; Saunders, PT | 1 |
| Lièvre, M; Sitruk-Ware, R | 1 |
| Hayes, JL; Kapp, N; Lohr, PA; Ngo, TD | 1 |
| Bennasar, M; Berge, R; Eixarch, E; Font, C; Illa, M; Palacio, M | 1 |
| Chen, QJ; Cheng, LN; Hong, QQ; Hou, SP; Huang, YM; Meads, C; Zhu, HP | 1 |
| Kelly, T; Lie, M; May, C; Robson, S | 1 |
| Aliberti, C; Bastianelli, C; Farris, M; Parachini, M | 1 |
| Di Carlo, C; Ferrara, C; Morra, I; Nappi, C; Savoia, F; Sglavo, G | 1 |
| Di Carlo, C; Ferrara, C; Morra, I; Perriera, L; Saccone, G; Sansone, A; Sglavo, G | 1 |
| Blum, J; Frye, LJ; Kilfedder, C; Winikoff, B | 1 |
13 review(s) available for mifepristone and alprostadil
| Article | Year |
|---|---|
The use of progesterone antagonists in combination with prostaglandin for termination of pregnancy.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Alprostadil; Cervix Uteri; Clinical Trials as Topic; Dinoprostone; Drug Synergism; Female; Humans; Laminaria; Mifepristone; Misoprostol; Multicenter Studies as Topic; Myometrium; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Progesterone; Randomized Controlled Trials as Topic; Uterine Contraction | 1994 |
Mifepristone/gemeprost to abort early pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Female; Humans; Mifepristone; Pregnancy; Prostaglandins E, Synthetic | 1993 |
Methods of abortion in Europe during the first trimester of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Alprostadil; Anesthetics; Dilatation and Curettage; Europe; Female; Humans; Mifepristone; Misoprostol; Patient Acceptance of Health Care; Pregnancy; Pregnancy Trimester, First | 1997 |
[Early medical abortion. An update].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Alprostadil; Drug Therapy, Combination; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First | 1999 |
Medical termination of pregnancy.
Topics: Abortifacient Agents; Abortion, Induced; Alprostadil; Contraindications; Drug Combinations; Female; Humans; Methotrexate; Mifepristone; Pregnancy; Progesterone; Prostaglandins; Uterine Contraction | 2000 |
[Early termination of pregnancy with pharmacological means].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Alprostadil; Drug Therapy, Combination; Female; Humans; Mifepristone; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First | 2000 |
Options for early therapeutic abortion: a comparative review.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Therapeutic; Alprostadil; Drug Therapy, Combination; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Pregnancy, Ectopic; Randomized Controlled Trials as Topic; Treatment Outcome; Vacuum Curettage | 2002 |
Prostaglandins for first-trimester termination.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Alprostadil; Cervical Ripening; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Pregnancy Tests; Pregnancy Trimester, First; Prostaglandins, Synthetic; Self Administration | 2003 |
[Induction of labour: which method to use?].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Adrenal Cortex Hormones; Alprostadil; Catheterization; Dinoprostone; Estrogens; Female; Humans; Interleukin-8; Labor, Induced; Mifepristone; Oxytocin; Pregnancy; Prostaglandins; Relaxin | 2003 |
Medical methods for first-trimester abortion.
Topics: Abortifacient Agents; Abortion, Induced; Alprostadil; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prostaglandins; Tamoxifen; Treatment Outcome | 2004 |
Meta-analysis of 200 or 600 mg mifepristone in association with two prostaglandins for termination of early pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Alprostadil; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Outcome Assessment, Health Care; Pregnancy; Randomized Controlled Trials as Topic | 2009 |
Cervical preparation for first trimester surgical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Alprostadil; Cervical Ripening; Dinoprost; Dinoprostone; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 2010 |
Mifepristone in combination with prostaglandins for termination of 10-16 weeks' gestation: a systematic review.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Alprostadil; Carboprost; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Prostaglandins; Randomized Controlled Trials as Topic | 2011 |
37 trial(s) available for mifepristone and alprostadil
| Article | Year |
|---|---|
Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Dinoprostone; Drug Evaluation; Female; France; Humans; Mifepristone; Pregnancy; Prostaglandins E, Synthetic | 1992 |
A study of gemeprost alone, dilapan or mifepristone in combination with gemeprost for the termination of second trimester pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Adult; Alprostadil; Female; Humans; Middle Aged; Mifepristone; Pessaries; Polymers; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies | 1992 |
What do women want during medical abortion?
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Acetaminophen; Administration, Oral; Adolescent; Adult; Alprostadil; Bias; Codeine; Female; Heroin; Humans; Mifepristone; Misoprostol; Pain; Patient Satisfaction; Pessaries; Pregnancy | 1992 |
Medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Alprostadil; Female; Humans; Mifepristone; Pregnancy | 1992 |
Medical abortion in women of less than or equal to 56 days amenorrhoea: a comparison between gemeprost (a PGE1 analogue) alone and mifepristone and gemeprost.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Amenorrhea; Drug Therapy, Combination; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First | 1992 |
Pregnancy termination with mifepristone and gemeprost: a multicenter comparison between repeated doses and a single dose of mifepristone. World Health Organization.
Topics: Abortion, Induced; Adult; Alprostadil; China; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Estradiol; Female; Hemoglobins; Humans; Hydrocortisone; Mifepristone; Peptide Fragments; Pregnancy; Progesterone; Prolactin; Prospective Studies; Random Allocation | 1991 |
Pre-operative cervical preparation before first trimester vacuum aspiration: a randomized controlled comparison between gemeprost and mifepristone (RU 486).
Topics: Abortifacient Agents, Nonsteroidal; Administration, Oral; Adolescent; Adult; Alprostadil; Cervix Uteri; Dilatation; Female; Humans; Mifepristone; Pessaries; Pregnancy; Pregnancy Trimester, First; Preoperative Care; Vacuum Curettage | 1991 |
[Contraceptive activity of RU486 and oral active prostaglandin combination].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Legal; Administration, Oral; Adult; Alprostadil; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 1991 |
The efficacy and tolerance of mifepristone and prostaglandin in first trimester termination of pregnancy. UK Multicentre Trial.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Legal; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Alprostadil; England; Female; Humans; Middle Aged; Mifepristone; Multicenter Studies as Topic; Pregnancy; Pregnancy Trimester, First; Prostaglandins E, Synthetic; Scotland | 1990 |
Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Double-Blind Method; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Randomized Controlled Trials as Topic; Time Factors | 1990 |
Induction of early abortion with mifepristone (RU486) and two different doses of prostaglandin pessary (gemeprost).
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Therapeutic; Adult; Alprostadil; Chorionic Gonadotropin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estrenes; Female; Humans; Mifepristone; Pessaries; Pregnancy; Random Allocation | 1989 |
Clinical trials with RU 486 (mifepristone): an update.
Topics: 16,16-Dimethylprostaglandin E2; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Alprostadil; Clinical Trials as Topic; Dinoprostone; Female; Humans; Labor, Induced; Mifepristone; Pregnancy; Pregnancy Trimester, Second | 1989 |
Therapeutic abortion in early pregnancy with antiprogestogen RU486 alone or in combination with prostaglandin analogue (gemeprost).
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Therapeutic; Administration, Intravaginal; Alprostadil; Drug Combinations; Estrenes; Female; Hemorrhage; Humans; Mifepristone; Nausea; Pregnancy; Pregnancy Trimester, First | 1986 |
Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Adult; Alprostadil; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pessaries; Pregnancy; Treatment Outcome | 1995 |
Reducing the induction to abortion interval in termination of second trimester pregnancies: a comparison of mifepristone with laminaria tent.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Legal; Adolescent; Adult; Alprostadil; Female; Humans; Laminaria; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Prospective Studies; Time Factors | 1995 |
Menstrual regulation by mifepristone plus prostaglandin: results from a multicentre trial. World Health Organization Task Force on Post-Ovulatory Methods of Fertility Regulation.
Topics: Abortion, Induced; Alprostadil; Drug Therapy, Combination; Female; Hemoglobins; Humans; Menstrual Cycle; Menstruation Disturbances; Mifepristone; Pregnancy; Prostaglandins E, Synthetic; Treatment Outcome; World Health Organization | 1995 |
Psychological responses following medical abortion (using mifepristone and gemeprost) and surgical vacuum aspiration. A patient-centered, partially randomised prospective study.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Anesthesia, General; Female; Gestational Age; Humans; Mifepristone; Pregnancy; Prospective Studies; Vacuum Curettage | 1994 |
A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae.
Topics: Abortion, Induced; Alprostadil; Female; Humans; Mifepristone; Postoperative Complications; Pregnancy; Vacuum Curettage | 1994 |
RU486: the French experience.
Topics: Abdominal Pain; Abortion, Induced; Adult; Alprostadil; Contraindications; Dinoprostone; Female; France; Humans; Hypotension; Mifepristone; Misoprostol; Myocardial Infarction; Pilot Projects; Pregnancy; Uterine Hemorrhage | 1994 |
The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).
Topics: Abortifacient Agents, Nonsteroidal; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Alprostadil; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Mifepristone; Misoprostol; Pessaries; Pregnancy; Pregnancy Trimester, Second | 1993 |
Termination of pregnancy with reduced doses of mifepristone. World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Mifepristone; Pessaries; Pregnancy; Treatment Outcome | 1993 |
Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Choice Behavior; Female; Humans; Mifepristone; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Pregnant Women; Vacuum Curettage | 1993 |
Blood loss in termination of early pregnancy by vacuum aspiration and by combination of mifepristone and gemeprost.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Adult; Alprostadil; Dose-Response Relationship, Drug; Female; Hemoglobins; Humans; Mifepristone; Pregnancy; Suction; Uterine Hemorrhage | 1993 |
Blood loss in termination of early pregnancy with mifepristone and gemeprost.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Alprostadil; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Uterine Hemorrhage | 1995 |
Misoprostol is as effective as gemeprost in termination of second trimester pregnancy when combined with mifepristone: a randomised comparative trial.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Alprostadil; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 1996 |
Termination of early human pregnancy with either 50 mg or 200 mg single oral dose of mifepristone (RU486) in combination with either 0.5 mg or 1.0 mg vaginal gemeprost.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Alprostadil; Double-Blind Method; Drug Combinations; Female; Humans; Mifepristone; Pregnancy; Prospective Studies; Treatment Outcome | 1996 |
A randomised study of two doses of gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Adolescent; Adult; Alprostadil; Dose-Response Relationship, Drug; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Time Factors | 1996 |
Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Choice Behavior; Female; Follow-Up Studies; Health Status; Humans; Mental Health; Mifepristone; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Reproductive Medicine; Vacuum Extraction, Obstetrical | 1997 |
Oral mifepristone 600 mg and vaginal gemeprost for mid-trimester induction of abortion. An open multicenter study. UK Multicenter Study Group.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Alprostadil; Female; Follow-Up Studies; Humans; Mifepristone; Time Factors; Treatment Outcome; United Kingdom | 1997 |
Interruption of early pregnancy with mifepristone in combination with gemeprost.
Topics: Abdominal Pain; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Alprostadil; Drug Therapy, Combination; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Time Factors; Treatment Outcome; Uterine Hemorrhage | 1999 |
Termination of second trimester pregnancy with mifepristone and gemeprost. The clinical experience of 197 consecutive cases.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Alprostadil; Female; Humans; Mifepristone; Parity; Pessaries; Pregnancy; Pregnancy Trimester, Second; Time Factors | 2000 |
Medical abortion at 57 to 63 days' gestation with a lower dose of mifepristone and gemeprost. A randomized controlled trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Alprostadil; China; Double-Blind Method; Drug Administration Schedule; Europe; Female; Georgia (Republic); Hong Kong; Humans; India; Mifepristone; Pregnancy; Pregnancy Trimester, First; Slovenia; Treatment Outcome; United States | 2001 |
Lowering the doses of mifepristone and gameprost for early abortion: a randomised controlled trial. World Health Organization Task Force on Post-ovulatory Methods for Fertility Regulation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Alprostadil; Double-Blind Method; Female; Humans; Mifepristone; Pregnancy; Treatment Outcome | 2001 |
Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Adult; Alprostadil; Double-Blind Method; Drug Synergism; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Treatment Outcome | 2001 |
A randomised study of misoprostol and gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Oral; Alprostadil; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pessaries; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Tablets | 2002 |
Medical versus surgical abortion efficacy, complications and leave of absence compared in a partly randomized study.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Adult; Alprostadil; Denmark; Female; Humans; Mifepristone; Postoperative Complications; Pregnancy; Sick Leave; Surveys and Questionnaires; Treatment Outcome; Vacuum Curettage | 2004 |
Medical versus surgical abortion: comparing satisfaction and potential confounders in a partly randomized study.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Alprostadil; Choice Behavior; Female; Gestational Age; Humans; Mifepristone; Patient Satisfaction; Pregnancy; Treatment Failure | 2005 |
52 other study(ies) available for mifepristone and alprostadil
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Multiple fetal anomalies in the first trimester; detection using transvaginal ultrasound and therapeutic abortion using mifepristone (RU486) in conjunction with gemeprost vaginal pessaries.
Topics: Abnormalities, Multiple; Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Administration, Oral; Adult; Alprostadil; Female; Humans; Mifepristone; Pessaries; Pregnancy; Ultrasonography, Prenatal | 1992 |
The efficacy of oral Mifepristone (RU 38,486) with a prostaglandin E1 analog vaginal pessary for the termination of early pregnancy: complications and patient acceptability.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Oral; Adult; Alprostadil; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Female; Follow-Up Studies; Humans; Mifepristone; Patient Acceptance of Health Care; Peptide Fragments; Pessaries; Pregnancy; Pregnancy Trimester, First | 1990 |
Changes in circulating alphafetoprotein following administration of mifepristone in first trimester pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; alpha-Fetoproteins; Alprostadil; Female; Fetomaternal Transfusion; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First | 1990 |
Medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Legal; Alprostadil; Female; Humans; Mifepristone; Pregnancy; Risk Assessment; United Kingdom | 1992 |
A pilot study of acceptability of RU486 and ONO 802 in a Chinese population.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; China; Female; Humans; Mifepristone; Patient Acceptance of Health Care; Pilot Projects; Pregnancy; Vacuum Curettage | 1991 |
Voluntary interruption of pregnancy with mifepristone (RU 486) and a prostaglandin analogue. A large-scale French experience.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Alprostadil; Dinoprostone; Drug Evaluation; Female; Humans; Mifepristone; Pregnancy; Retrospective Studies; Time Factors; Uterine Hemorrhage | 1990 |
Blood loss following induction of early abortion using mifepristone (RU 486) and a prostaglandin analogue (gemeprost).
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Therapeutic; Alprostadil; Drug Therapy, Combination; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Premedication; Uterine Hemorrhage | 1989 |
Circulating levels of placental protein 12 and chorionic gonadotrophin following RU 38486 and gemeprost for termination of first trimester pregnancy.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Alprostadil; Carrier Proteins; Chorionic Gonadotropin; Estrenes; Female; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Proteins; Mifepristone; Pregnancy; Pregnancy Proteins | 1989 |
Circulating levels of placental protein 14 and progesterone following Mifepristone (RU38486) and Gemeprost for termination of first trimester pregnancy.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Alprostadil; Estrenes; Female; Glycodelin; Glycoproteins; Humans; Mifepristone; Pregnancy; Pregnancy Proteins; Pregnancy Trimester, First; Progesterone | 1989 |
Receptor-mediated effects of glucocorticoids on inflammation: enhancement of the inflammatory response with a glucocorticoid antagonist.
Topics: Alprostadil; Animals; Carrageenan; Dexamethasone; Estrenes; Glucocorticoids; Inflammation; Kinetics; Leukocytes; Leukotriene B4; Male; Mifepristone; Rats; Rats, Inbred Strains; Receptors, Glucocorticoid | 1988 |
Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Therapeutic; Administration, Oral; Adolescent; Adult; Alprostadil; Chorionic Gonadotropin; Drug Evaluation; Estrenes; Female; Follow-Up Studies; Humans; Mifepristone; Pessaries; Pregnancy; Prostaglandins E, Synthetic | 1987 |
Acceptability of medical pregnancy termination.
Topics: Abortion, Induced; Alprostadil; Consumer Behavior; Dilatation and Curettage; Estrenes; Female; Humans; Mifepristone; Pregnancy; Vacuum Curettage | 1988 |
[Abortion induced by RU 486: importance of its combination with a prostaglandin derivative].
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Administration, Oral; Alprostadil; Drug Interactions; Estrenes; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Prostaglandins E, Synthetic; Suppositories | 1988 |
Prostaglandins and antigestagens for the interruption of early pregnancy.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Therapeutic; Alprostadil; Estrenes; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First | 1988 |
Early pregnancy termination: a comparison between vacuum aspiration and medical abortion using prostaglandin (16,16 dimethyl-trans-delta 2-PGE1 methyl ester) or the antiprogestogen RU 486.
Topics: Abortion, Therapeutic; Adult; Alprostadil; Dilatation and Curettage; Drug Therapy, Combination; Estrenes; Female; Follow-Up Studies; Humans; Mifepristone; Pessaries; Pregnancy; Pregnancy Trimester, First; Vacuum Curettage | 1988 |
Changes in the concentration of alpha-fetoprotein and placental hormones following two methods of medical abortion in early pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Adult; alpha-Fetoproteins; Alprostadil; Chorionic Gonadotropin; Estradiol; Female; Fetomaternal Transfusion; Humans; Mifepristone; Placental Hormones; Pregnancy; Progesterone; Time Factors | 1993 |
A novel inhibitory role for glucocorticoids in the secretion of angiotensinogen by C6 glioma cells.
Topics: 1-Methyl-3-isobutylxanthine; Alprostadil; Angiotensinogen; Animals; Bucladesine; Cyclic AMP; Dexamethasone; Dinoprost; Dose-Response Relationship, Drug; Glioma; Isoproterenol; Liver Neoplasms, Experimental; Mifepristone; Rats; Tumor Cells, Cultured | 1994 |
Uterine rupture during therapeutic abortion in the second trimester using mifepristone and prostaglandin.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Therapeutic; Alprostadil; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Uterine Rupture | 1995 |
Uterine rupture during therapeutic abortion in the second trimester using mifepristone and prostaglandin.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Alprostadil; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Uterine Rupture | 1995 |
Effects of gemeprost and mifepristone on the mechanical properties of the cervix prior to first trimester termination of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Oral; Adolescent; Adult; Alprostadil; Cervix Uteri; Female; Humans; Mifepristone; Obstetrics; Pessaries; Pregnancy; Pregnancy Trimester, First | 1995 |
RU486 combined with PGE1 analog in voluntary termination of early pregnancy--a comparison of recent findings with gemeprost or misoprostol.
Topics: Abortion, Induced; Adult; Alprostadil; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Retrospective Studies; Time Factors; Uterine Hemorrhage | 1994 |
Medical abortion in Britain.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Incomplete; Abortion, Induced; Alprostadil; Day Care, Medical; Drug Costs; Female; Humans; Mifepristone; Patient Acceptance of Health Care; Pregnancy | 1994 |
Termination of a molar pregnancy using mifepristone and gemeprost.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Female; Humans; Hydatidiform Mole; Mifepristone; Pregnancy; Uterine Neoplasms | 1994 |
Cardiogenic pulmonary oedema: presentation of pre-eclampsia exacerbated by prostaglandin abortifacients.
Topics: Abortifacient Agents, Nonsteroidal; Adolescent; Alprostadil; Critical Care; Female; Humans; Mifepristone; Pre-Eclampsia; Pregnancy; Prostaglandins E, Synthetic; Pulmonary Edema | 1994 |
Further acceptability evaluation of RU486 and ONO 802 as abortifacient agents in a Chinese population.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; China; Female; Humans; Mifepristone; Pregnancy | 1993 |
Induction of abortion in early pregnancy with mifepristone in conjunction with gemeprost.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Adolescent; Adult; Alprostadil; Drug Therapy, Combination; Female; Humans; Middle Aged; Mifepristone; Pessaries; Pregnancy | 1993 |
Induction of second trimester abortion with mifepristone and gemeprost.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Oral; Adolescent; Adult; Alprostadil; Female; Humans; Mifepristone; Pessaries; Pregnancy; Pregnancy Trimester, Second; Prospective Studies; Time Factors; Treatment Outcome | 1993 |
Clinical use of mifepristone (RU 486).
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Alprostadil; Dinoprostone; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 1993 |
Toxic epidermal necrolysis after mifepristone/gemeprost-induced abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Alprostadil; Female; Hormone Antagonists; Humans; Mifepristone; Pregnancy; Prostaglandins E, Synthetic; Stevens-Johnson Syndrome | 1996 |
The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation; UK Multicentre Study--final results.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Alprostadil; Female; Humans; Middle Aged; Mifepristone; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; United Kingdom | 1997 |
Fetal malformation and failed medical termination of pregnancy.
Topics: Abnormalities, Drug-Induced; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Alprostadil; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Prostaglandins E, Synthetic; Risk Factors; Treatment Failure | 1998 |
Gestational regulation of granulocyte-colony stimulating factor receptor expression in the human placenta.
Topics: Abortifacient Agents, Steroidal; Alprostadil; Blotting, Western; Decidua; Female; Gene Expression Regulation; Gestational Age; Humans; Immunohistochemistry; Mifepristone; Oxytocin; Placenta; Pregnancy; Receptors, Granulocyte Colony-Stimulating Factor; Ribonucleases; RNA, Messenger; Trophoblasts | 1999 |
[Reintroduction of medical abortion in Denmark].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Adolescent; Adult; Alprostadil; Denmark; Female; Humans; Mifepristone; Pregnancy; Prostaglandins E, Synthetic; Retrospective Studies | 2000 |
Medical termination of early pregnancy: the Swedish experience.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Legal; Alprostadil; Female; Humans; Mifepristone; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Public Opinion; Sweden; Vacuum Curettage | 2000 |
[Vasospastic angina pectoris following abortion induced by prostaglandin analogue].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Alprostadil; Angina Pectoris, Variant; Electrocardiography; Female; Humans; Mifepristone; Pregnancy; Prostaglandins E, Synthetic | 2000 |
Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Age Factors; Alprostadil; Contraceptives, Postcoital, Synthetic; Female; Gestational Age; Humans; Mifepristone; Parity; Pregnancy; Pregnancy Trimester, First; Retrospective Studies; Statistics, Nonparametric; Treatment Outcome | 2000 |
Second trimester termination of pregnancy for fetal anomaly or death: comparing mifepristone/misoprostol to gemeprost.
Topics: Abnormalities, Multiple; Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Administration, Intravaginal; Administration, Oral; Adult; Alprostadil; Female; Fetal Death; Humans; Maternal Age; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Reproductive History; Retrospective Studies; Treatment Outcome | 2001 |
Second trimester medical abortion with mifepristone and gemeprost: a review of 956 cases.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Alprostadil; Female; Humans; Mifepristone; Pessaries; Pregnancy; Pregnancy Trimester, Second; Treatment Outcome; United Kingdom | 2001 |
Medical termination of pregnancy at 9-12 weeks of gestation.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Alprostadil; Drug Therapy, Combination; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Prostaglandins E, Synthetic; Retrospective Studies | 2002 |
Glucocorticoid involvement in suppression of NK activity following surgery in rats.
Topics: Alprostadil; Animals; Cimetidine; Corticosterone; Cytotoxicity, Immunologic; Dinoprostone; Glucocorticoids; Immune Sera; Injections, Subcutaneous; Killer Cells, Natural; Kinetics; Laparotomy; Male; Mifepristone; Postoperative Period; Rats; Rats, Inbred F344; Suppressor Factors, Immunologic; Tumor Cells, Cultured | 2003 |
[Large variation in clinical regimens use to induce medical abortion in Denmark].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Alprostadil; Denmark; Female; Follow-Up Studies; Humans; Mifepristone; Misoprostol; Practice Patterns, Physicians'; Pregnancy; Surveys and Questionnaires | 2003 |
Medical abortion. defining success and categorizing failures.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Adolescent; Adult; Alprostadil; Denmark; Female; Gestational Age; Humans; Middle Aged; Mifepristone; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Treatment Failure | 2003 |
Role of routine ultrasonography in monitoring the outcome of medical abortion in a clinical setting.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Alprostadil; Ambulatory Care Facilities; Diagnostic Tests, Routine; Female; Follow-Up Studies; Humans; Mifepristone; Misoprostol; Pregnancy; Reproducibility of Results; Retrospective Studies; Treatment Outcome; Ultrasonography; Uterus | 2004 |
Leukocyte populations and steroid receptor expression in human first-trimester decidua; regulation by antiprogestin and prostaglandin E analog.
Topics: Abortifacient Agents; Alprostadil; Decidua; Female; Hormone Antagonists; Humans; Immunohistochemistry; Killer Cells, Natural; Leukocyte Count; Macrophages; Mifepristone; Neutrophils; Pregnancy; Pregnancy Trimester, First; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone | 2005 |
Acute coronary artery vasospasm associated with misoprostol for termination of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Analgesics; Chest Pain; Coronary Vasospasm; Coronary Vessels; Female; Humans; Ketoprofen; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Tromethamine | 2010 |
'Let the computer choose?': the experience of participants in a randomised preference trial of medical versus surgical termination of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Choice Behavior; Female; Follow-Up Studies; Health Status; Humans; Mental Health; Mifepristone; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Randomized Controlled Trials as Topic; Reproductive Medicine; Vacuum Extraction, Obstetrical | 2012 |
Second-trimester induced abortions in two tertiary centres in Rome.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Alprostadil; Congenital Abnormalities; Drug Therapy, Combination; Female; Gestational Age; Humans; Mifepristone; Parity; Pregnancy; Pregnancy Trimester, Second; Rome; Socioeconomic Factors | 2014 |
Effects of a prolonged, 72 hours, interval between mifepristone and gemeprost in second trimester termination of pregnancy: a retrospective analysis.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Adult; Alprostadil; Curettage; Drug Administration Schedule; Female; Humans; Mifepristone; Pessaries; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies; Treatment Outcome; Young Adult | 2014 |
Incidence of uterine rupture in second-trimester abortion with gemeprost alone compared to mifepristone and gemeprost.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Cesarean Section; Drug Therapy, Combination; Female; Humans; Incidence; Italy; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies; Uterine Rupture; Young Adult | 2019 |
A cross-sectional analysis of mifepristone, misoprostol, and combination mifepristone-misoprostol package inserts obtained in 20 countries.
Topics: Abortifacient Agents; Abortion, Induced; Alprostadil; Cross-Sectional Studies; Developing Countries; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Product Labeling; Treatment Outcome | 2020 |